Relapsing-remitting multiple sclerosis is a type of ... When myelin is damaged, nerves become inflamed, making it difficult for your brain to communicate with the rest of your body.

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis (MS) have the ...

Nerves send and receive messages from every part of your body and process them in your brain ... In relapsing-remitting MS, symptoms may worsen during flare-ups due to inflammation but then ...

So we'll go online, and I'll see this relapsing, remitting ... have these inflammatory active changes that will occur. What you're having is this inflammatory attack on the brain.

This mechanism of action provides the rationale for use in relapsing–remitting multiple ... multiple sclerotic lesions or plaques disseminated throughout the brain and spinal cord, and ...

So what we know is that from a neurologic standpoint, lesions in the brain and atrophy of the brain, which occurs in both relapsing MS ... Well, inflammation, systemic inflammation has been ...

reports a reduced incidence of gadolinium-enhancing lesions—indicative of inflammatory activity in the CNS—in patients with relapsing–remitting multiple sclerosis (MS). Compared with placebo ...

Multiple sclerosis, the prototype of demyelinating disease in man, is a relapsing-remitting or progressively ... axon transection can occur in inflammatory lesions, and axonal loss is closely ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

In addition, relative brain ... relapsing-remitting and progressive phenotypes and supports the notion that both mechanisms are present in all patients and at all stages, with an overlap of ...

Multiple Sclerosis (MS) is an autoimmune, inflammatory condition of the central nervous system. Relapsing MS (formerly known as Relapsing Remitting MS ... that cross-reacts with a water channel in the ...

Background: Alemtuzumab (Lemtrada®) is a newly approved therapeutic agent for relapsing-remitting multiple sclerosis ... suppressing autoimmune inflammatory responses in the central nervous ...